Interleukin-17 Inhibitor in Treatment of Psoriasis during COVID-19 Pandemic: An Ambispective Study

Interleukin-17 Inhibitor in Treatment of Psoriasis during COVID-19 Pandemic: An Ambispective Study

Introduction: Psoriasis is a genetically mediated chronic inflammatory disease that is frequently associated with metabolic co-morbidities. These metabolic co-morbidities have a huge impact in deciding the appropriate immunosupressant of choice in the current scenario of Coronavirus Disease (COVID-1...

Full description

Bibliographic Details
Main Authors: Ramesh Aravamudhan, V Sampath, Rajkumar Kannan, Parimalam Kumar, Venkatesan Srinivasan, MM Sridevi
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
coronavirus disease
psoriasis vulgaris
psoriasis area and severity index scores
secukinumab
vaccine
Online Access:https://www.jcdr.net/articles/PDF/17381/59172_CE(Vi)_F(IS)_PF1(SC_KM)_PFA(AsG_KM)_PN(KM).pdf

Internet

https://www.jcdr.net/articles/PDF/17381/59172_CE(Vi)_F(IS)_PF1(SC_KM)_PFA(AsG_KM)_PN(KM).pdf

Similar Items